Skip to main content
Log in

Current status of tissue engineering for cardiovascular structures

  • Tissue Engineering: Review
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Various vascular and valvlular grafts are commonly used in the treatment of cardiovascular disease. Current prosthetic or bioprosthetic materials lack growth potential, and therefore, subsequent replacement further defeats the concept of primary repair early in pediatric cardiac patients. Tissue engineering is a new discipline that offers the potential to create replacement structures from autologous cells and biodegradable polymer scaffolds. Because tissue-engineering constructs contain living cells, they may have the potential for growth, self-repair, and self-remodeling. Cardiac valve leaflets and large conduits in the pulmonary ciruulation have been made with this tissue-engineering approach in lambs. Venous conduits were also created in dogs. Mixed cell populations of endothelial cells and fibroblasts were isolated from explanted peripheral arteries or vein. A synthetic biodegradable scaffold con-sisting of polyglactin and polyglycolic acid fibers was seeded in vitro with mixed cultured cells. After one week, these autologous cell/polymer constructs were reimplanted in animals. Each animal was then followed periodically by echocardiography and angiography. The animals were sacrificed, and the implanted tissues were examined histologically, biochemically, and biomechanically. A 4-hydroxyproline assay was performed to evaluate the collagen content. The implanted conduit diameters increased as the animals grew during the study period. Histologically, the biodegradable polymer scaffold was completely degraded. Collagen analysis of the constructs showed the development of an extracellular matrix. Immunohistochemical staining demonstrated elastin fiber in the matrix and factor VIII on the inner surface of the conduits. In conclusion, a tissue-engineering approach to constructing cardiovascular structures is feasible using cells of either arterial or venous origin. In these tissue-engineered autografts, transplanted autologous cells generated the proper matrix over the polymer scaffold under physiologic conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Langer R, Vacanti JP. Tissue engineering. Science, 1993;260:920–926

    PubMed  CAS  Google Scholar 

  2. Kirklin J, Barratt-Boyes B. Ventricular septal defect and pulmonary stenosis or atresia. In: Kirklin J, Barrat-Boyes B (eds) Cardiac surgery. New York: Churchill Livingstone, 1993;861–1012

    Google Scholar 

  3. Braunwald E. Valvular heart disease. In: Braunwald E (ed) Heart disease. 5th ed. Philadelphia: Saunders, 1992;1007–1076

    Google Scholar 

  4. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635–641

    PubMed  CAS  Google Scholar 

  5. Carpentier A. Congenital malformations of the mitral valve. In: Stark J, de Levcal M (eds) Surgery for congenital heart defects. 2nd ed. London: Grune & Stratton, 1983;599–614

    Google Scholar 

  6. Kirklin JK, Smith D, Novick W, Naffel DC, Kirklin JW, Pacifico A, Nanda NC, Helmeke FR, Bourge RC. Long-term function of cryopreserved aortic homografts. J Thorac Cardiovasc Surg 1993;106:154–166

    PubMed  CAS  Google Scholar 

  7. Shin'Oka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60:551–553

    Article  Google Scholar 

  8. Shin'Oka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE Jr. Creation of viable pulmonary autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536–545

    Article  Google Scholar 

  9. Shin'Oka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 1996;94(suppl II):

    Google Scholar 

  10. Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 1963;35:1961–1965

    Article  CAS  Google Scholar 

  11. Booyse FM, Sedlak BJ, Rafelson M Jr. Culture of arterial endothelial cells: characterization and growth of bovine aortic cells. Thromb Diath Haemorrh 1975;34:825–839

    PubMed  CAS  Google Scholar 

  12. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science 1999;284:489–493

    Article  PubMed  CAS  Google Scholar 

  13. Kim BS, Nikolovski J, Bonadio J. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nature Biotech 1999;17:979–981

    Article  CAS  Google Scholar 

  14. Huynh T, Abraham G, Murray J. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nature Biotech 1999;17:1083–1085

    Article  CAS  Google Scholar 

  15. Nerem RM, Braddon LG, Seliktar D. Tissue engineering and the vascular system. In: Atala A, Mooney DJ (eds) Synthetic Biodegradable polymer scaffolds. Boston: Birkhauser, 1997;165–185

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin'oka, T., Imai, Y., Watanabe, M. et al. Current status of tissue engineering for cardiovascular structures. J Artif Organs 3, 102–106 (2000). https://doi.org/10.1007/BF02479974

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02479974

Key words

Navigation